Doxazosin
NDC 16729-213, Doxazosin, tablet, from Accord Healthcare Inc..
- Product NDC
- 16729-213
- Status
- Listed
- Labeler
- Accord Healthcare Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202824
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE4 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-213-01 | 16729021301 | 100 TABLET in 1 BOTTLE (16729-213-01) |
| 16729-213-17 | 16729021317 | 1000 TABLET in 1 BOTTLE (16729-213-17) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2830533c-ccdf-4401-b19c-763eeb1bc0a7
Use it
Look up 16729-213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.